Alps Group Inc(ALPS)

Biotechnology · Kuala Lumpur, WP

$0.38-0.02 (-5.00%)

Delayed quote: Oct 6, 2026, 10:52 AM EDT

Alps Group (ALPS) EV/FCF: History & Chart | TGMCharts

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T14:55:44.111Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:55:44.111Z.

Quote observation: 2026-10-06T14:52:34.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 63,232,125
Total debt · period ending 2026-03-31: N/A
Cash · period ending 2026-03-31: N/A
TTM free cash flow · period ending 2025-09-30: N/A

FMP input reference: 473da95602fdb42a5f780e5c02853506da999e38a33e04168dea7648cb5c925f

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ALPS EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

ALPS Competitors' EV/FCF Ratio

ALPS

Alps Group Inc

Current

Market Cap

$63.23M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs ALPS

Market Cap

$63.30M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs ALPS

Market Cap

$61.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs ALPS

Market Cap

$64.68M

EV/FCF Ratio

14.63x

TTM Avg

12.61x

3Y Avg

12.61x

5Y Avg

118.68x

HRTX

Heron Therapeutics, Inc.

vs ALPS

Market Cap

$64.71M

EV/FCF Ratio

N/A

TTM Avg

1.41x

3Y Avg

1.41x

5Y Avg

1.41x

GOSS

Gossamer Bio, Inc.

vs ALPS

Market Cap

$64.94M

EV/FCF Ratio

N/A

TTM Avg

54.90x

3Y Avg

54.90x

5Y Avg

54.90x

INKT

MiNK Therapeutics, Inc.

vs ALPS

Market Cap

$60.53M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs ALPS

Market Cap

$60.72M

EV/FCF Ratio

N/A

TTM Avg

108.20x

3Y Avg

108.20x

5Y Avg

108.20x

CING

Cingulate Inc.

vs ALPS

Market Cap

$65.73M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GUTS

Fractyl Health, Inc.

vs ALPS

Market Cap

$59.36M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Alps Group Inc (ALPS)	$63.23M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$63.30M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$61.79M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$64.68M	14.63x	12.61x	12.61x	118.68x
Heron Therapeutics, Inc. (HRTX)vs ›	$64.71M	N/A	1.41x	1.41x	1.41x
Gossamer Bio, Inc. (GOSS)vs ›	$64.94M	N/A	54.90x	54.90x	54.90x
MiNK Therapeutics, Inc. (INKT)vs ›	$60.53M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$60.72M	N/A	108.20x	108.20x	108.20x
Cingulate Inc. (CING)vs ›	$65.73M	N/A	N/A	N/A	N/A
Fractyl Health, Inc. (GUTS)vs ›	$59.36M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

ALPS EV/FCF Ratio Metrics

ALPS Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics